Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

Show other versions (1)

Background: Emergence of drug-resistant cancer phenotypes is a challenge for anti-cancer therapy. Cancer stem cells are identified as one of the ways by which chemoresistance develops. Method: We investigated the anti-inflammatory combinatorial treatment (DA) of doxorubicin and aspirin using a precl...

Full description

Bibliographic Details
Main Authors: Khoo, Bee Luan, Grenci, Gianluca, Lim, Joey Sze Yun, Lim, Yan Ping, Fong, July, Yeap, Wei Hseun, Lim, Su Bin, Chua, Song Lin, Wong, Siew Cheng, Yap, Yoon-Sim, Lee, Soo Chin, Lim, Chwee-Teck, Han, Jongyoon
Other Authors: Singapore-MIT Alliance in Research and Technology (SMART)
Format: Article
Language:English
Published: 2020
Online Access:https://hdl.handle.net/1721.1/125700

Internet

https://hdl.handle.net/1721.1/125700

Similar Items